Dulaglutide inhibits high glucose- induced endothelial dysfunction and NLRP3 inflammasome activation

Ukraine's State Service on Medicines and Drugs Control webinar on licensing conditions for pharmaceutical establishments The State Service of Ukraine on Medicines and Drugs Control held the webinar Topic: Conducting economic activities in the field of circulation of narcotic drugs, psychotropic substances, and precursors by pharmaceutical (pharmacy) establishments, taking into account changes to the licensing conditions The State Service of Ukraine on Medicines and Drugs Control held the webinar on Conducting economic activities in the field of circulation of narcotic drugs, psychotropic substances, and precursors by pharmaceutical (pharmacy) establishments, taking into account changes to the licensing conditions for representatives of pharmaceutical (pharmacy) establishments, organized by the Department of State Regulation and Control in the Field of Circulation of Narcotic Drugs, Psychotropic Substances, Precursors, and Counteracting Their Illegal Circulation

While protocols vary by practitioner, here are a few common approaches being used in clinical settings: Note: These are off-label uses when not following FDA-approved dosing for obesity or diabetes
December 18 Product: AstraZenecas Andexxa Indication: Reversal of anticoagulation The FDA has declined to give traditional approval to AstraZenecas recombinant factor Xa therapy Andexxa, according to reporting from Pink Sheet last week
Most patients who add Lipo-C run it for 3-6 months alongside GLP-1 therapy, then reassess
Nutrition, resistance training, protein intake, hydration, medication side effects, and underlying disease all influence what weight loss means in practice